Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02030834 |
|---|---|
| Brief Title: | Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas |
| First Submitted : | January 7, 2014 |
| First Submitted that Met QC Criteria : | January 7, 2014 |
| First Posted : | January 9, 2014 (Estimate) |
| Results First Submitted : | September 9, 2020 |
| Results First Submitted that Met QC Criteria : | October 1, 2020 |
| Results First Posted : | October 5, 2020 |
| Last Update Submitted that Met QC Criteria : | June 20, 2023 |
| Last Update Posted : | June 22, 2023 |